March 16, 2021
1 min read

Iran’s vaccine enters final trial

The receivers of the COV-Iran Barekat vaccine were two lecturers at TUMS….reports Asian Lite News

https://www.youtube.com/watch?v=J8u7vepVfEo

Iran has kicked off the final stage of the clinical trial of its domestic Covid-19 vaccine as two volunteers were inoculated, semi-official Mehr news agency reported.

“Phase 1 was successfully completed with 56 volunteers, and today phases 2 and 3 of the clinical trial began,” director of the clinical trial centre at Tehran University of Medical Sciences (TUMS) Hamed Hosseini said on Monday.

The receivers of the COV-Iran Barekat vaccine were two lecturers at TUMS.

Iran has so far reported a total of 1,754,933 coronavirus cases and 61,330 deaths.

At least 1,499,301 Covid-19 patients have recovered, but 3,839 others remain in critical condition, according to official figures.

Also read:Iran’s special rapporteur on sanctions

Previous Story

‘Int’l diplomacy crucial for ending Syrian war’

Next Story

Israel allows int’l flights

Latest from -Top News

Trump tariffs send world markets into panic

US benchmark crude oil shed $2.70 to $64.25 a barrel after major oil producers announced they plan to increase production. Brent crude, the international standard, was down $2.63 at $67.51 a barrel

EU prepares retaliation for Trump’s tariffs

The European Commission is assembling a fresh round of counter-tariffs aimed at US goods, adding to two existing lists of potential targets—one of which includes products that were hit by suspended tariffs

US, EU slam China’s war games near Taiwan

US President Donald Trump underscored the need to maintain peace in the Taiwan Strait, advocating for a diplomatic approach to cross-strait tensions while warning against the use of force The United States

£13.9 billion of R&D fund to boost innovation, jobs

Funding outlined to support transformational R&D in areas like life sciences, green energy, engineering and beyond More UK innovators like those developing treatment-transforming dementia tests or building world-leading testing facilities to power
Go toTop